In-vivo and In-vitro Correlation for Delayed-release Behaviour of a Molsidomine/O-carboxymethyl-O-ethyl-β-cyclodextrin Complex in Gastric Acidity-controlled Dogs
- 1 February 1995
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 47 (2) , 124-127
- https://doi.org/10.1111/j.2042-7158.1995.tb05763.x
Abstract
The in-vivo absorption behaviour of molsidomine from the delayed-release tablets of an O-carboxy-methyl-O-ethyl-β-cyclodextrin complex was investigated using gastric acidity-controlled dogs under fasted and non-fasted conditions. The in-vitro release profiles were generated by changing the pH of the dissolution medium at different rotation paddle speeds. The absorptivity of molsidomine in the high acidity dog was correlated with the pH-changed release profile (pH 1·2 to 7·0 after 2 h), whereas that in the low acidity dog was correlated with the release profile at a constant pH of 7·0. The absorption in fasted dogs was well correlated with the in-vitro release at the low-rotation paddle speed (< 5 rev min−1), whereas that in the non-fasted dogs was correlated with that of high rotation (100 rev min−1). The present results suggested that the in-vivo delayed-release behaviour of the complex is predictable from the in-vitro release profiles generated using pH-variable dissolution testing apparatus at different rotation speeds of the paddle.Keywords
This publication has 12 references indexed in Scilit:
- Bioavailability of Hydroxychloroquine Tablets Assessed with Deconvolution TechniquesJournal of Pharmaceutical Sciences, 1992
- Stabilization of Prostaglandin E1 in Fatty Alcohol Propylene Glycol Ointment by Acidic Cyclodextrin Derivative, O-Carboxymethyl-O-ethyl-.BETA.-cyclodextrin.CHEMICAL & PHARMACEUTICAL BULLETIN, 1992
- Release control of theophylline by β-cyclodextrin derivatives: hybridizing effect of hydrophilic, hydrophobic and ionizable β-cyclodextrin complexesJournal of Controlled Release, 1991
- Improvement of Stability and Bioavailability of 1-Hexylcarbamoyl-5-fluorouracil (HCFU) by O-Carboxymethyl-O-ethyl-β-cyclodextrinYAKUGAKU ZASSHI, 1991
- Design and In Vitro Evaluation of Slow-Release Dosage Form of Pretanide: Utility of β-Cyclodextrin:Cellulose Derivative Combination as a Modified-Release Drug CarrierJournal of Pharmaceutical Sciences, 1990
- In Vitro and in Vivo Testing and Correlation for Oral Controlled/Modified-Release Dosage FormsPharmaceutical Research, 1990
- O-carboxymethyl-O-ethylcyclomalthoheptaose as a delayed-release-type drug carrier: improvement of the oral bioavailability of diltiazem in the dogCarbohydrate Research, 1989
- Cyclodextrin TechnologyPublished by Springer Nature ,1988
- Solubilization of drugs by modified β-cyclodextrinsInternational Journal of Pharmaceutics, 1985
- Amorphous Water-Soluble Derivatives of Cyclodextrins: Nontoxic Dissolution Enhancing ExcipientsJournal of Pharmaceutical Sciences, 1985